Genomictree will hold an investor relations (IR) session for domestic institutional investors on July 6.

According to a regulatory filing by Genomictree on the 3rd, this IR will take place in meeting rooms at respective institutional investors' offices, including those in Yeouido, Seoul. The event is scheduled to run from 9:00 AM to 2:00 PM on that day.

This event, conducted as an in-person meeting, has been organized to enhance investors' understanding of the company. The company plans to explain its current status during the IR session and hold a question-and-answer (Q&A) period with attendees.

Meanwhile, the sponsoring institution for this IR is Mirae Asset Securities, and the event date has been confirmed for July 3, 2026.